Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bioverse vs Ilant Health

Bioverse
Graded #232

Higher grade

vs+8.200000000000003
Ilant Health
Graded #408

Lower grade

The verdict

Bioverse takes it — 65/100 to 56.8/100.

Bioverse grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bioverse (GoBioverse) offers compounded semaglutide and tirzepatide plus brand-name Ozempic, Wegovy, and Mounjaro.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBioverse +22
67
45
Dose & formulationBioverse +37
77
40
Clinical oversightIlant Health +9
74
83
Labs & monitoringIlant Health +8
53
61
FulfillmentEven
62
62
Contract termsIlant Health +22
33
55
Bioverse · left barIlant Health · right bar

The numbers

MetricBioverseIlant Health
WeighScore65/10056.8/100
GradeCC
Scorecard rank#232#408
Semaglutide$129/mo (starting dose, compounded)Not disclosed
Tirzepatide$399/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Bioverse

Graded #232 · C

Strengths

  • Wide formulary — compounded and brand-name semaglutide + tirzepatide plus metformin
  • No membership, cancellation, doctor, or hidden fees
  • Uses US-licensed, FDA-regulated pharmacies

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • State availability not disclosed beyond 'a provider licensed in your state'
  • Broader longevity platform (NAD+, B12, glutathione, hair, skincare, heart health) rather than GLP-1 focused
Ilant Health

Graded #408 · C

Strengths

  • Value-based, outcomes-driven obesity care model
  • Includes GLP-1 medications with transparent drug pricing for sponsors
  • Care team of board-certified obesity providers and behavioral specialists
  • Dietitians and peer navigators support adherence
  • Data-driven stratification targets the right interventions

Where it loses points

  • Distributed via employers and health plans, not direct cash-pay
  • Individuals generally cannot enroll without sponsor coverage
  • No public consumer pricing for GLP-1
  • Access gated behind organizational buyers
  • Not suited to consumers wanting direct-to-door GLP-1

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard